• Endometrial carcinoma: Systemic therapies. Part 1 - The physicians' perspective

  • Dec 6 2023
  • Duración: 29 m
  • Podcast

Endometrial carcinoma: Systemic therapies. Part 1 - The physicians' perspective Por arte de portada

Endometrial carcinoma: Systemic therapies. Part 1 - The physicians' perspective

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Join world-renowned gynaecological oncology experts Dr Domenica “Ketta” Lorusso and Dr Mansoor Mirza as they explore the changing landscape of systemic treatment in endometrial carcinoma. Single-agent immunotherapies (pembrolizumab and dostarlimab), and now immunotherapy and antiangiogenic therapy combinations (pembrolizumab and lenvatinib), are transforming treatment pathways, with OS benefits in the second-line now achievable. They offer tips for managing the toxicity of these novel therapeutic options and set the stage for 2023, a year which promises a paradigm shift in the use of systemic treatments in this once underserved malignancy.
    Más Menos
activate_primeday_promo_in_buybox_DT
Más Menos

Lo que los oyentes dicen sobre Endometrial carcinoma: Systemic therapies. Part 1 - The physicians' perspective

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles